VedaBio vs Alphabet Inc.
Side-by-side comparison of AI visibility scores, market position, and capabilities
Precision genome editing biotech developing base and prime editors for rare genetic diseases; improved specificity over first-generation CRISPR competing with Beam Therapeutics and Intellia.
About
Veda Bio is a biotechnology company developing novel therapeutics for rare genetic diseases and cancer using its proprietary precision genome editing platform — enabling targeted genetic corrections with greater specificity and reduced off-target editing compared to first-generation CRISPR tools. Founded in 2019 and headquartered in Seattle, Washington, Veda Bio was founded by genome editing pioneers and has raised early-stage funding to develop its differentiated editing technology platform.\n\nVeda Bio's platform focuses on delivering precision genetic medicine that can address root causes of genetic diseases rather than managing symptoms. The company's approach aims to improve on first-generation CRISPR-Cas9 by developing base editors and prime editors that can make specific genetic corrections (single letter DNA changes, small insertions or deletions) without introducing double-strand DNA breaks that create higher off-target editing risk. This precision is critical for therapeutic applications where off-target genomic changes could have serious safety consequences.\n\nIn 2025, Veda Bio operates in the competitive genome editing therapeutics space alongside Intellia Therapeutics, Beam Therapeutics (base editing pioneer), Prime Medicine, and CRISPR Therapeutics. The genome editing field experienced a landmark moment in 2023 with the FDA approval of Casgevy (the first CRISPR-based therapy, for sickle cell disease and beta-thalassemia, developed by Vertex and CRISPR Therapeutics) — validating the genome editing therapeutic modality and creating competitive pressure for improved precision editing platforms. Veda Bio's 2025 strategy focuses on advancing lead programs in rare genetic indications through preclinical development toward IND applications, publishing research to establish scientific credibility, and exploring partnerships or licensing with larger biopharmaceuticals for clinical development.
Mountain View AI and digital advertising conglomerate (NASDAQ: GOOGL) $350B FY2024 revenue (+15%); Google Search 90%+ share, Google Cloud $43.2B (+30%), Gemini AI, DOJ monopoly ruling 2024.
About
Alphabet Inc. is a Mountain View, California-based technology conglomerate — publicly traded on the NASDAQ (NASDAQ: GOOGL, GOOG) as an S&P 500 Information Technology component — operating as the holding company for Google (Search, YouTube, Google Ads, Gmail, Google Cloud, Android, Chrome, Maps, Play Store, Workspace), and Other Bets (Waymo autonomous vehicles, DeepMind AI research, Verily life sciences, Wing drone delivery, Google Fiber) through approximately 183,000 full-time employees. In fiscal year 2024, Alphabet reported revenues of $350 billion (+15% year-over-year), with Google Services (Search, YouTube, Google Play, subscriptions) generating $307 billion, Google Cloud generating $43.2 billion (+30%), and Other Bets $2.0 billion, while generating $100 billion in net income — reflecting Alphabet's position as one of the highest-profit companies in history, funded by Google Search's advertising monopoly (processing 8.5+ billion searches daily, commanding 90%+ global search market share). CEO Sundar Pichai has prioritized Alphabet's AI-first transformation: the 2024 launch of Gemini Ultra 1.0, Gemini 1.5 Pro (1 million token context window — largest at launch), and Gemini 2.0 Flash positioned Google as a competitive AI frontier model lab alongside OpenAI, following the ChatGPT disruption that temporarily threatened Google's search advertising dominance in 2023. Google Cloud's Vertex AI platform (enterprise AI model deployment with Gemini, Llama, and third-party models) and Google Distributed Cloud (air-gapped government cloud) compete directly with Microsoft Azure AI and AWS SageMaker for enterprise AI workload contracts. Waymo's commercial robotaxi operations in San Francisco, Phoenix, and Los Angeles (Waymo One — fully driverless rides, generating revenue and operational data) represent Alphabet's highest-upside long-duration investment.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.